Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD476 (Mesalazine) in Acute Mild to Moderate Ulcerative Colitis
NCT00503243Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2003
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Takeda. Started Sep 2003; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00503243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503243.